Aquaporin 9 downregulation in KRASG12V colorectal cancer and associated with increased proliferation and decreased apoptosis in cancer cells

Abstract Patients with colorectal cancer (CRC) carrying KRAS mutations face a challenging prognosis, especially due to their reduced response to EGFR inhibitor therapies. Despite the use of drugs targeting the KRASG12C mutation, the KRASG12V mutation is more common in CRC, and unfortunately, there a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yankui Liu, Jiahao Dou, Qi Tan, Shuning Chen, Yaru Li, Rong Wang, Ning Sun, Xiaowei Qi
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-95513-w
Tags: Add Tag
No Tags, Be the first to tag this record!